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Introduction
Chronic heart failure (CHF) is a chronic disabling
condition most commonly caused by left ventricular
systolic dysfunction (LVSD)1. The incidence and
prevalence of CHF have increased so markedly over
recent decades, that it is considered to constitute an
‘epidemic’2. Current estimates are that between 6%
and 10% of people aged over 65 have CHF3,4. How-
ever, the majority of the cost of treating CHF arises
from inpatient care as hospitalizations for CCHF are
frequent, lengthy and costly5 with around 16% of
patients hospitalized more than once each year6.
The potential to improve outcomes in CHF has in-
creased markedly in recent decades. Patients should
be offered a range of therapies including diuretics,
ACE-inhibitors or/and angiotensin receptor blockers,
beta blockers, aldosterone blockers and digoxin. Pa-
tients also receive support to make lifestyle changes
such as increasing physical activity, restricting salt,
stop smoking and reducing weight7,8.
However, a significant proportion of adverse
outcomes, particularly admission to hospital with
decompensated CHF, have been attributed to patient
factors, especially poor self management of medica-
tions9. The psycho-motor and cognitive changes that
are a common consequence of CHF have been asso-
ciated with this low compliance10,11. Patients have
also been shown to have a limited knowledge of CHF
and its management12,13. Psycho-social factors can
also negatively influence the use of health services and
CHF outcomes14–16. Health professionals appear to do
little to address these multiple barriers12,17, and in
particular, patients with CHF receive limited help in
medication management18,19.
New models of care for chronic diseases have led to
health professionals being urged to work more effec-
tively in multi-disciplinary teams and to provide more
accessible support for home-based management20,21.
As a part of that team, pharmacists in the United
Kingdom have been encouraged to become more
involved in medication self-management in priority
areas such as heart disease22–24. Studies have reported
the positive effect of supportive interventions pro-
vided by pharmacists on the quality of care and other
outcomes in CHF25–30. However, while policy sug-
gests that pharmacy services may be well suited to
provide help to those with CHF in the commu-
nity22,24, current research has focused on more com-
pliant patients29 and little is known about how the
pharmacist can optimally support patients’ and care-
givers’ medication needs. It is also not known how
patients with CHF and caregivers currently use phar-
macists and how willing they would be to accept
greater pharmacist input to their care in the future.
We therefore examined these issues further in a
qualitative study of CHF patients and their caregivers
from the West of Scotland.
Methods
We undertook a qualitative study exploring the per-
spectives of 50 people with CHF (33 males: mean age
67 years; 17 females: mean age 68 years), and 30 of
their nominated principal caregivers. Participants
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Study objectives: (1) To identify the medication management
needs of chronic heart failure (CHF) patients and their care-
givers; (2) To examine the perceived support for medication
management available to these people from health profes-
sionals; (3) To identify the actual and potential perceived
contribution of pharmacists to medication management.
Setting: A mixed urban/ rural region in the west of Scotland.
Design: Semi-structured qualitative research interviews.
Participants: A total of 50 people with CHF (NYHA Class II and III)
due to left ventricular systolic dysfunction (33 males; mean age
67 years, 17 females; mean age 68 years) and 30 nominated
caregivers recruited from the outpatient departments of two
hospitals in the West of Scotland. Sampling was purposive to
include patients from a range of CHF severity, ages and sexes.
Main results: Managing medications was a responsibility shared
by both the patients with CHF and caregivers. Treatment regi-
mens were reported to be difficult to comply with. Health
professionals were seen to provide little support for medication
management. Pharmacists were viewed as being a good and
accessible source of practical assistance who were also knowl-
edgeable about the individual’s heart health history. Partici-
pants reported valuing advice from pharmacists about the side
effects of medications and for their assistance in reducing the
complex logistics of medication management and in having
medications delivered.
Conclusions: Patients with CHF and caregivers voiced a will-
ingness to try to manage their medication regimen accurately
but had a limited capacity to do so. Pharmacists were viewed as
providing valuable support to patients with CHF and their
caregivers, in terms of medication management. The extended
role of pharmacists in medication management of CHF should
be encouraged.
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two hospitals serving urban/ rural populations in the
West of Scotland. Purposive sampling included
individuals from a range of severity of CHF, age
and sex. Sample size was determined by the need
to have sufficient numbers of each sex and NYHA
class to allow meaningful comparisons31. Inclusion
criteria of the sample were less than 80 years of
age, one or more hospital admissions for CHF due
to LVSD, NYHA Class II or III CHF (i.e. mild to
moderately severe symptoms) and no known
dementia. The study was passed by the relevant
ethics committees.
Patient perspectives were explored using a semi-
structured interview that examined knowledge and
management of CHF, experience of symptoms and
views of health needs, health professionals and health
services (Table 1) with a series of core questions in-
cluded in the schedule (Table 2). With the exception
of two interviews undertaken at a University, all
interviews were undertaken in participants’ homes.
With participants’ permission, all interviews were
audio-taped. Participants were advised that they
could withdraw at any time, their identities would
remain confidential and their care would not be af-
fected by their participation. Data were transcribed by
a secretary and to ensure reliability, were initially
analyzed independently by AMC and MER who then
compared interpretations for each interview.
Based on data collected during the first 10 inter-
views, a coding framework was developed that could
subsume all the current themes. The framework was
discussed and entered into qualitative analysis soft-
ware (NUDIST) and used to categorize subsequent
interviews. It was essential that all relevant data should
be subsumed into the analytical framework and that
the framework, which was modified by the research
team, was organized accurately into appropriate
themes and sub-themes. In this paper abbreviations
have been used based on pseudonyms of patients and
their caregiver.
Results
Patients and caregivers reported at length the steps
that they took daily to cope with and manage CHF.
The main management tasks undertaken every day
included regulating activity levels, monitoring the
body for troublesome signs of worsening CHF and
managing the medication regimen. The regimen
contained treatments commonly recommended for
CHF, with the most common drugs prescribed being
loop diuretics and ACE-inhibitors. A mean number of
8.96 drugs (range: 4–21 tablets) were consumed
daily.
Participants frequently voiced how important it was
to manage their condition on an ongoing basis, but
though they recognized that managing medication
was integral to this, they had little knowledge of how
the medications affected the CHF (this aspect is dis-
cussed in more detail elsewhere)32. In most instances,
patients reported that taking tablets in accordance
with their prescription was important because of the
perceived moral obligations they felt to their health
professionals and the faith they had in their cardiolo-
gists’ expertise. However, the practical task of man-
aging medications in accordance with the prescribed
regimen was seen widely as being very challenging.
The most common difficulty was avoiding running
out of supplies of particular tablets (Box 1).
Role of health professionals
With the exception of dealing with acute episodes of
symptom exacerbation, most health professionals
(primarily family physicians and cardiologists) were
viewed by patients as making little contribution to
educate patients about CHF and had limited insight
into management and information needs (Box 2a).
Caregivers were also unable to provide much support
in these areas as they too shared these deficits
(Box 2b).
Two-thirds of patients interviewed used commercial
or home-made pill boxes to organize medications for
each day, but the use of these devices had been
suggested by other family members or friends rather
than by health care professionals. While family phy-
sicians and cardiologists were consulted about symp-
toms which persisted, the professionals’ role was
perceived mainly to be in designing and adjusting
the medication regimen, rather than supporting or
Table 2 Core questions in the interview
Views of heart failure
When did the breathlessness/ fluid retention/
fatigue start?
What was going on to cause this?
Personal effects of CHF on life
How is your life now different than before the
heart failure?
What things did you like to do but now
find difficult?
Medication/ Symptom management
What helps your symptoms/ heart failure?
How do you think your tablets work?
What do they do?
What are the main things you find difficult
about the tablets?
How often have you forgotten to take them?
What happens if you stop taking them?
What do you do when you forget to take them?
Do you ever change the doses? In what
situations do you do this?
What do you do when you run out of a
prescription? (if applicable)
Table 1 Main interview themes
Patient questions
Views of heart failure
Biological effects of CHF







Personal effects of heart failure
Health Professionals
Care-giving role
guiding their daily consumption. Even during periods
in which symptoms worsened, access to a family
doctor, especially one who knew them, was reported
as being slow. Many patients also reported not wish-
ing to ‘trouble’ their doctor, and deliberately delayed
or avoided consulting. Their view was that their
problems were relatively minor compared to others
that the busy physicians faced.
Box 1 Perceived difficulties with managing heart failure medications
Running out of supplies of tablets
Probably the longest (that I was without medications) was over a weekend because the surgery is shut...and I
have been too late for handing in for my repeat prescription. And you can’t get the prescription until the
following Monday. Because the pills are all over the place...they are all staggered because you have got
them started at different times. So you are maybe running out of the aspirin, and you have still got plenty
of the frusemide left.
(Mr G, 45 years old, NYHA Class II)
I was running out (of tablets). But then I worked with my doctor and I am getting the whole lot at once. I
told the doctor ‘It’s too many (tablets)’...There might be a couple of days difference between a couple of
them, but I could go down and get my new prescription and I might have a couple of days left in that
tablet, four days left on that, a day left on that.
(Mr B, 66 years old NYHA Class III)
Box 2a Health professionals and CHF management (Patients)
They (health professionals) never told me a thing, then one doctor said to me ‘You have got this heart
disease which is incurable and you will just have to live with it. There is no cure for it. You can’t get an
operation, you can’t get nothing.’ ...He just told me to take things easy. He would never explain anything
to me, he was very negative...But that was all I got out of him.
(Mr B, 67 years old, NYHA Class III)
I felt at times that I would go to my doctor and I said ‘I am not coping well with this or that.’ He said ‘Well,
what do you expect? You have got a bad heart.’ And before I knew it, I was out the door. I said (to
myself) ‘Wait a minute I didn’t even get a chance to ask him anything!’ I could have done with a bit more
advice on how to cope. I felt sometimes as soon as you went in he sorts of looked at his watch...Within a
minute I was out that door. This isn’t right, I was disappointed...I wasn’t too happy about that, I went up
the road thinking ‘This was a waste of time, it wasn’t worth the effort me going down there out in the
cold air.’
(Mr R, 68 years old, NYHA Class III)
My heart is not pumping. My heart is not going fast enough to pump the water away and I wasn’t taking my
water pills the way I should have. I didn’t realise how important the water pills were. One day the doctor
said ‘Are you still taking them?’ and I said ‘No.’ He said ‘You are off your head!’ I said: ‘Nobody was asking
me, so I didn’t bother with them, just through ignorance...’ Nobody explained how important it was to
me. I just got fed up taking them, running to the toilet, running to the toilet. If I had realized how
important it was, I wouldn’t have stopped it. I just didn’t bother because nobody else was bothering so I
didn’t bother.
(Mr L, 70 years old, NYHA Class II)
Box 2b Health professionals and CHF management (Caregivers)
He [patient] has been in and out of hospital that often and I took the doctor down to the door [to see him
out]. And he said to me ‘Has anybody ever told you, Mrs L, how serious this is?’ I said ‘No,’ well they
hadn’t. He said ‘Well it’s very serious...’
(Mrs W, NYHA Class III, spouse).
Mrs H: No I am quite an independent person, I would (contact the doctor) myself because he (husband)
doesn’t like going into hospitals, so he would try and talk me out of it. No I take the decision – I will make
(it) myself.
(Mrs H, NYHA Class III spouse)
Mrs J (caregiver) : I said (to partner with CHF): ‘Go to the doctors,’ and he said ‘No,’ and I said I would get
the doctor and he said that he would see how he was on Monday. So on Monday he said ‘Oh if I am not
better by Tuesday phone the doctor.’ Well by Monday night... he couldn’t get up because he couldn’t
breath and he had difficulty getting up the stairs.
Mr J: I don’t like going to the doctor...I just feel they have got enough to do with people that have really bad
problems. I have never had anything like that, so I thought it was just trivial, just a cold.
(Mrs J, NYHA Class II spouse)
Box 3b Practical support
I got a new set of tablets and I just got the other ones [as well] and I said ‘What the hell am I going to do with
them?’ So I took them back to the chemist. They lay there for a while and then I took them to the
chemist...I would always take them to the chemist, I wouldn’t throw them in the bin.
(Mr B, 67 years old, NYHA Class III)
Mrs S: If I only have got another week of tablets left, then I will phone in for my prescription. I never leave
myself any less than a week that I have got to fill in that.
Mr S (caregiver): We did go short. Then if you were short the chemist would give you something...
Mrs S: That was just recently I did it I got five tablets off the chemist and then he would get that off my
prescription, I got five. If you go to the same chemist, they know you and they know what tablets you are
on.
(Mr S, 75 years old, NYHA Class III)
The chemist...if for any reason I ran out of tablets...there is the odd time I have got stuck like that. So I said to
(the pharmacist) ‘I have run out of these I should be taking them this morning.’ He says ‘Right, are you
putting your prescription in?’ and I say ‘Yes it is already in,’ but it might have been a weekend or something
like that. He would maybe give [me] ten and say ‘Right, I will write this in my book, and when you get your
prescription, bring it in’ and he takes ten off your prescription. He wouldn’t see me stuck, that is quite
reassuring. I suppose strictly speaking, he shouldn’t do that.
(Mr R., 68 years old, NYHA Class III)
We can get the tablets delivered, the chemist actually deliver them to your door so it’s quite easy that way...
Probably the longest I have been without tablets is over the weekend because the surgery is shut. I have done
that...when I have been too late for handing in for my repeat prescription. And you can’t get it until the
following Monday. Again, you’re only talking about one tablet, because the pills are all over the place...they
are all staggered because you have got them started at different times.
(Mr G. 45 years old, NYHA Class II)
Box 3a Pharmacists role in CHF medication management
An accessible first point of contact
I tend to go to the doctor if there is something wrong that I think might be serious. You read things in the
newspapers and you add them all up and think ‘I may have that’...I had a cough for 2 weeks, a dry cough
and I went to the chemist and she said you should go to the doctor and it turned out to be pleurisy. That
cleared up after two lots of antibiotics...
(Mr J, 69 year old, NYHA Class II)
Mr C: I usually check with the chemist because one time we were going to take something – a flu treatment –
and he told us not to, because of the tablet I was on. I checked with him because he has got a note of all
the tablets I am on. He would tell us: ‘Is this for yourself? Oh I don’t advise it.’
(Mr B, 67 years old, NYHA Class III)
I went on a certain tablet a while ago – my doctor put me on it. And I had a rash, so I went and asked the
chemist. And she told us (caregiver also) something that the doctor hadn’t, that is something to do with
the heart I am not blaming the doctor but it happened and the chemist is able to say something.
(Mrs Y, 51 years old, NYHA Class II)
A good source of knowledge
The chemist I go to, if I go in there and ask for a tablet that is not on my prescription, they have got me on
record on the computer. And they say ‘Wait and I will see if you can get that Mr H.’ And they will say ‘no’,
they say ‘You can’t get that you will need to see your doctor.’
(Mr H, 77 years old, NYHA Class III)
If I have a cough, I take a cough bottle or I take an antibiotic from the doctor...the chemist I go to, if I go
there and ask for something off the prescription, they have got me on the computer. And they say ‘Wait
and I will see if you can get that. Oh you can’t get that, you will need to see your doctor.’
(Mrs O, 72 years old, NYHA Class III)
Close relationships with pharmacists
I have on occasions run out of tablets, not often but on occasion. Fortunately I have been going to the same
chemist for years. He knows me and will give me medication. I will in turn phone up the surgery and say I
ran out, and I owe the chemist whatever, and they will sort it out.
(Mrs A, 60 years old, NYHA Class II)
Mr D: I get the repeat prescription at that small chemist round the corner there.
Mrs D (caregiver) We are well known round there so if there was an emergency he would give us it straight
away. So if he ever ran out we have never been without a tablet. We have always went round and said
‘Can I get a couple until we get the prescription...’ We did it as he was on over 20-odd tablets...
(Mr D, 76 years old, NYHA Class II)
The support offered by pharmacists
In contrast to other health professionals, participants
identified pharmacists as being a first point of call for
questions related to CHF and management (Box 3a).
Easy access was important and they felt they could
more readily gain advice from their local pharmacist.
No appointment was needed and no other profes-
sional or geographical barriers were seen to inhibit a
rapid ‘consultation’. Advice was sought most often on
the possible side effects of medications, possible drug
interactions or contra-indications between existing
and new prescribed or ‘‘over-the-counter’’ medica-
tions and for symptom management. Pharmacists
were seen as having a good knowledge of each of
these areas. Because relationships with the same
pharmacist had often been established over consider-
able time, the pharmacist was seen as being knowl-
edgeable both about CHF and individual’s heart health
history in a similar way to that of the family physician.
Participants also reported that pharmacists pro-
vided practical support that was particularly useful in
easing the complex logistics involved in medication
management (Box 3b). Three types of support pro-
vided by pharmacists were particularly valued.
First, the most common management difficulty cited
by participants was avoiding running out of medica-
tion. In some instances patients did inadvertently run
out of stocks of medications before repeat prescriptions
could be ordered. In these cases, if the patient was
known to pharmacist, he or she often supplied a small
number of tablets until the repeat prescription arrived.
While the ethics of such a practice might be debated, it
did prevent distress and reduced the likelihood of
symptom exacerbation and rehospitalization.
Secondly, participants reported taking medications
that were expired or left-over from previous pre-
scriptions back to pharmacists for disposal. By dis-
posing of these medications, pharmacists acted to
limit the volume of additional medications that had to
be retained and ‘managed’ in the home.
Finally, participants reported that some pharmacies
would deliver medications to their homes. Both pa-
tients and caregivers reported that they found this
service reassuring, knowing that in the event of a
sudden change in their circumstances (e.g. symptom
worsening or illness) they would not be left without
their medication.
Discussion
This study demonstrates that patients with CHF and
their caregivers have a range of unmet needs related
to medication, including poor knowledge, lack of
support and poor access to health professionals. Par-
ticipants demonstrated a willingness to undertake
home-based management of CHF but reported a
limited capacity to deal with the logistical complexity
of their medication regimens. While most participants
responded proactively to their difficulties, such as by
using commercial or home-made pill boxes, many
would have benefited from more practical support
and education about CHF and its management.
A range of personal and organizational factors may
limit physicians’ capacity to provide effective CHF
management including awareness of evidence33,
sectorial boundaries33 and the lack of social and pal-
liative care services to supplement stretched medical
care. Pharmacists constitute a professional group well
placed to address these challenges. In this study,
pharmacists were seen as being accessible and help-
ful. This group was also seen as being knowledgeable
about CHF, its management and, importantly, about
the individual. Unlike some family physicians, the
pharmacist was seen to be approachable and inter-
acted co-operatively and productively with patients
and caregivers.
Low compliance with medication regimens is an
international problem that has significant and negative
consequences for patients and health systems34,35.
Participants implicitly recognized that pharmacists
could contribute effectively to home-based disease
management as part of the wider health care team.
This more collaborative and multi-disciplinary ap-
proach to health care is highly congruent with current
health policy20,23, models of chronic disease man-
agement36,37 and contemporary approaches to med-
ication management23,34,35. Physicians should work
collaboratively with local pharmacists as part of health
care teams to improve support for patients with CHF
and their caregivers.
In terms of method, the interview was effective at
eliciting participants’ beliefs about CHF, and the re-
ported medication management. Furthermore, it was
successful in identifying salient themes the researchers
had not anticipated, most notably with the role of
pharmacists in assisting their care. Due to the high rates
of premature heart disease in the West of Scotland, the
patients may be slightly younger than elsewhere and
patients over 80 years of age were excluded due to
possible co-morbidity in this group. The transferability
of the findings to other settings is increased by the
relatively large sample size for a qualitative study, the
balanced nature of the sample across sex and NYHA
classification and the lack of a local specialist service for
CHF support at the time of the study.
Conclusion
The positive view of patients about pharmacists in this
study suggests that these professionals have a con-
siderable potential to play an extended role in the
management of CHF. They are seen by patients and
caregivers as accessible and a useful source of support
for medication management.
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